Your browser is no longer supported. Please, upgrade your browser.
Settings
PGEN Precigen, Inc. daily Stock Chart
PGEN [NASD]
Precigen, Inc.
Index- P/E- EPS (ttm)-1.14 Insider Own1.00% Shs Outstand164.07M Perf Week-9.11%
Market Cap802.58M Forward P/E- EPS next Y-0.51 Insider Trans411.00% Shs Float151.39M Perf Month25.43%
Income-180.00M PEG- EPS next Q-0.14 Inst Own67.00% Short Float19.66% Perf Quarter0.23%
Sales91.70M P/S8.75 EPS this Y57.60% Inst Trans0.41% Short Ratio24.87 Perf Half Y13.44%
Book/sh0.30 P/B14.63 EPS next Y36.30% ROA-70.50% Target Price- Perf Year-13.24%
Cash/sh0.73 P/C6.03 EPS next 5Y2.40% ROE-295.00% 52W Range1.26 - 7.28 Perf YTD-19.89%
Dividend- P/FCF- EPS past 5Y-10.10% ROI-69.70% 52W High-39.70% Beta1.84
Dividend %- Quick Ratio2.50 Sales past 5Y4.80% Gross Margin37.60% 52W Low248.41% ATR0.42
Employees770 Current Ratio2.70 Sales Q/Q-7.30% Oper. Margin- RSI (14)46.98 Volatility8.50% 9.57%
OptionableYes Debt/Eq4.51 EPS Q/Q-26.40% Profit Margin- Rel Volume0.41 Prev Close4.33
ShortableYes LT Debt/Eq3.86 Earnings- Payout- Avg Volume1.20M Price4.39
Recom2.30 SMA201.71% SMA50-8.15% SMA2006.15% Volume492,422 Change1.39%
May-08-20Initiated H.C. Wainwright Buy $5
Oct-23-20 10:30PM  
02:10PM  
12:00PM  
11:19AM  
Oct-22-20 08:54PM  
Oct-21-20 07:55PM  
07:26PM  
07:00PM  
06:21PM  
12:00PM  
11:00AM  
Oct-20-20 08:10PM  
04:00PM  
09:13AM  
07:30AM  
Oct-19-20 07:15PM  
03:40PM  
11:35AM  
Oct-17-20 04:22PM  
Oct-16-20 06:00PM  
04:47PM  
04:33PM  
01:22PM  
11:00AM  
11:00AM  
Oct-15-20 06:22PM  
04:56PM  
01:45PM  
12:17PM  
11:00AM  
07:30AM  
Oct-14-20 08:00PM  
06:00PM  
05:00PM  
11:30AM  
11:00AM  
Oct-13-20 09:40PM  
Oct-12-20 05:54PM  
04:21PM  
03:20PM  
12:00PM  
10:00AM  
10:00AM  
Oct-09-20 06:45PM  
02:18PM  
07:31AM  
Oct-08-20 08:00PM  
07:33PM  
06:15PM  
04:52PM  
03:40PM  
09:00AM  
Oct-07-20 06:35PM  
06:19PM  
02:30PM  
01:20PM  
11:00AM  
10:07AM  
Oct-06-20 08:15PM  
07:00PM  
06:04PM  
04:13PM  
03:22PM  
01:05PM  
01:00PM  
09:47AM  
Oct-05-20 11:00PM  
08:00PM  
07:50PM  
06:34PM  
05:49PM  
12:58PM  
09:47AM  
Oct-03-20 03:42PM  
01:36PM  
Oct-02-20 09:12PM  
06:00PM  
05:02PM  
04:30PM  
03:20PM  
12:44PM  
Sep-08-20 07:30AM  
Aug-21-20 11:14AM  
Aug-17-20 07:30AM  
Aug-10-20 04:10PM  
07:30AM  
Aug-06-20 07:30AM  
Aug-03-20 07:30AM  
Jun-22-20 08:45AM  
Jun-11-20 07:30AM  
Jun-10-20 09:35AM  
Jun-04-20 04:05PM  
May-21-20 02:27PM  
May-15-20 07:30AM  
Apr-29-20 07:30AM  
Apr-20-20 07:36AM  
Mar-02-20 04:05PM  
Feb-24-20 07:30AM  
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; proprietary methane bioconversion platform that turns natural gas into energy and chemical products; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch inducible gene switch that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with ZIOPHARM Oncology, Inc.; Ares Trading S.A.; Oragenics, Inc.; Intrexon T1D Partners, LLC; Intrexon Energy Partners, LLC; Intrexon Energy Partners II, LLC; Fibrocell Science, Inc.; OvaXon, LLC; S & I Ophthalmic, LLC; Harvest start-up entities; and Surterra Holdings, Inc. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ares Trading S.A.10% OwnerOct 07Buy3.706,758,40024,999,99727,398,519Oct 09 08:09 AM
Sterling Rick L.Chief Financial OfficerSep 16Sale5.227,66039,985305,313Sep 17 06:39 PM
Perez Jeffrey ThomasSVP, IP AffairsSep 16Sale5.227,66039,985243,229Sep 17 06:35 PM
Lehr Donald P.Chief Legal OfficerSep 16Sale5.228,47444,234248,084Sep 17 06:29 PM
KIRK RANDAL JExecutive ChairmanAug 12Buy4.26400,8661,707,68913,495,622Aug 13 04:24 PM
KIRK RANDAL JExecutive ChairmanAug 11Buy4.50808,5183,638,33113,216,701Aug 13 04:24 PM
Sabzevari HelenPresident and CEOJul 20Sale4.5812,22055,968402,145Jul 21 06:40 PM
Frank StevenDirectorJun 30Option Exercise3.172,9689,409265,563Jul 06 04:22 PM
ALVAREZ CESAR LDirectorJun 23Option Exercise3.172,9689,409184,133Jun 25 04:22 PM
MITCHELL DEAN JDirectorJun 19Option Exercise3.172,9689,409105,441Jun 23 04:57 PM
Lehr Donald P.Chief Legal OfficerJun 16Sale4.508,42837,926231,558Jun 17 04:35 PM
Perez Jeffrey ThomasSVP, IP AffairsJun 16Sale4.507,61934,286225,889Jun 17 04:32 PM
Sterling Rick L.Chief Financial OfficerJun 16Sale4.507,61934,286287,973Jun 17 04:32 PM
Lehr Donald P.Chief Legal OfficerMay 18Sale2.3662,895148,659214,986May 19 04:33 PM
Sterling Rick L.Chief Financial OfficerMay 18Sale2.3656,853134,372270,592May 19 04:34 PM
Perez Jeffrey ThomasSVP, IP AffairsMay 18Sale2.3656,853134,372208,508May 19 04:33 PM
Sabzevari HelenPresident and CEOMay 15Sale2.37217,527515,800389,365May 18 04:04 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.